Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Shilovskii IP"'
Autor:
Emel'yanova AG; 1Laboratory of Physiologically Active Substances, Department of Molecular and Cellular Pathophysiology, Research Institute of General Pathology and Pathophysiology, Moscow, Russia. agemelyanova@gmail.com., Grechenko VV; Research and Production Company Materia Medica Holding, Moscow, Russia., Petrova NV; 1Laboratory of Physiologically Active Substances, Department of Molecular and Cellular Pathophysiology, Research Institute of General Pathology and Pathophysiology, Moscow, Russia., Shilovskii IP; State Research Centre Institute of Immunology, Federal Medical-Biological Agency of the Russian Federation, Moscow, Russia., Gorbunov EA; Research and Production Company Materia Medica Holding, Moscow, Russia., Tarasov SA; Research and Production Company Materia Medica Holding, Moscow, Russia., Khaitov MR; State Research Centre Institute of Immunology, Federal Medical-Biological Agency of the Russian Federation, Moscow, Russia., Morozov SG; 1Laboratory of Physiologically Active Substances, Department of Molecular and Cellular Pathophysiology, Research Institute of General Pathology and Pathophysiology, Moscow, Russia., Epshtein OI; 1Laboratory of Physiologically Active Substances, Department of Molecular and Cellular Pathophysiology, Research Institute of General Pathology and Pathophysiology, Moscow, Russia.
Publikováno v:
Bulletin of experimental biology and medicine [Bull Exp Biol Med] 2017 Jan; Vol. 162 (3), pp. 323-326. Date of Electronic Publication: 2017 Jan 14.
Autor:
Emelianova AG; Laboratory of Physiologically Active Substances, Department of Molecular and Cellular Pathology and Pathophysiology, Research Institute of General Pathology and Pathophysiology, Moscow, Russia. agemelianova@gmail.com., Shilovskii IP; State Research Center Institute of Immunology, Federal Medical-Biological Agency, Moscow, Russia., Sundukova MS; State Research Center Institute of Immunology, Federal Medical-Biological Agency, Moscow, Russia., Khaitov MR; State Research Center Institute of Immunology, Federal Medical-Biological Agency, Moscow, Russia., Epshtein OI; Laboratory of Physiologically Active Substances, Department of Molecular and Cellular Pathology and Pathophysiology, Research Institute of General Pathology and Pathophysiology, Moscow, Russia.
Publikováno v:
Bulletin of experimental biology and medicine [Bull Exp Biol Med] 2016 Oct; Vol. 161 (6), pp. 806-807. Date of Electronic Publication: 2016 Oct 26.
Publikováno v:
Eksperimental'naia i klinicheskaia farmakologiia [Eksp Klin Farmakol] 2016 Aug; Vol. 79 (4), pp. 35-44.